Prosecution Insights
Prosecution Insights
5 pending office actions • 1 client • 5 examiners • 4 art units • 0 of 5 (0%) have an AI response strategy ready • 5 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 only | 2 (40%) |
| §103 only | 1 (20%) |
| §112 only | 1 (20%) |
| No statute on record | 1 (20%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| ROBINSON, MIKHAIL O'DONNEL | 1 | 57.5% | +42.7% |
| DAVIS, BRIAN J | 1 | 84.8% | -4.2% |
| AEDER, SEAN E | 1 | 56.7% | +20.0% |
| XU, XIAOYUN | 1 | 59.7% | +32.2% |
| JOHANSEN, PETER N. | 1 | 59.4% | +22.8% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18193917 | METHODS FOR THE DETECTION AND TREATMENT OF LUNG CANCER | AEDER, SEAN E | — |
| 18145602 | METHODS FOR THE DETECTION AND TREATMENT OF PROSTATE CANCER | XU, XIAOYUN | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17310262 | METAL CHELATOR COMBINATION THERAPY FOR THE TREATMENT OF CANCER | JOHANSEN, PETER N. | 14d |
| 18787216 | INHIBITORS OF MUTANT IDH1 AND IDH2 | ROBINSON, MIKHAIL O'DONNEL | — |
| 18193917 | METHODS FOR THE DETECTION AND TREATMENT OF LUNG CANCER | AEDER, SEAN E | — |
| 18145602 | METHODS FOR THE DETECTION AND TREATMENT OF PROSTATE CANCER | XU, XIAOYUN | — |
| Client (Assignee) | Pending OAs |
|---|---|
| University of Texas | 5 |
| Art Unit | Apps |
|---|---|
| 1614 | 1 |
| 1642 | 1 |
| 1797 | 1 |
| 1644 | 1 |
| App # | Title | Client | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|---|
| 18787216 | INHIBITORS OF MUTANT IDH1 AND IDH2 | BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM | ROBINSON, MIKHAIL O'DONNEL | §112 | Non-Final OA | — | Pending | Jul 29, 2024 | |
| 18734176 | CYCLIC DINUCLEOTIDES AS AGONISTS OF STIMULATOR OF INTERFERON GENE DEPENDENT SIGNALLING | BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM | DAVIS, BRIAN J | 1614 | — | Non-Final OA | — | Pending | Jun 05, 2024 |
| 18193917 | METHODS FOR THE DETECTION AND TREATMENT OF LUNG CANCER | BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM | AEDER, SEAN E | 1642 | §101 | Non-Final OA | — | Pending | Mar 31, 2023 |
| 18145602 | METHODS FOR THE DETECTION AND TREATMENT OF PROSTATE CANCER | BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM | XU, XIAOYUN | 1797 | §101 | Non-Final OA | — | Pending | Dec 22, 2022 |
| 17310262 | METAL CHELATOR COMBINATION THERAPY FOR THE TREATMENT OF CANCER | BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM | JOHANSEN, PETER N. | 1644 | §103 | Final Rejection | 14d | Pending | Jul 27, 2021 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial